Roscovitine in B-chronic lymphocytic leukemia cells: high apoptosis-inducing efficacy and synergism with alemtuzumab independent of the patients’ pretreatment status
oleh: Eva Weingrill, Albert Wölfler, Dirk Strunk, Werner Linkesch, Heinz Sill, Peter M. Liebmann
| Format: | Article |
|---|---|
| Diterbitkan: | Ferrata Storti Foundation 2007-09-01 |
Deskripsi
Roscovitine induced apoptosis in isolated B-chronic lymphocytic leukemia cells of 25 patients of whom nine with relapsed and seven with fludarabine-refractory disease. It was synergistic with alemtuzumab and restored sensitivity to alemtuzumab in initially alemtuzumab-resistant samples. Observed roscovitine-induced up-regulation of CD52 surface expression may be one of the underlying mechanisms for this synergism.